Uncovering the neurobiological mechanisms of delta opioid receptor agonists

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions, current medications have several limitations, including slow action and adverse effects with long-term use. This underscores the urgent need for novel, rapidly-acting therapeutic agents with minimal side effects. The delta opioid receptor (DOP) … Read more

Brain maturation delays linked to unhealthy eating behaviors in youth

More than half of 23-year-olds in a European study show restrictive, emotional or uncontrolled eating behaviors, according to new research led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London. Structural brain differences appear to play a role in the development of these eating habits. The study, published in Nature Mental … Read more

Ketamine Shows Promise in Treating Uncontrollable Movements in Parkinson’s Patients

Archyde Could Ketamine Be a Breakthrough Treatment for Parkinson’s Disease? Table of Contents 1. Could Ketamine Be a Breakthrough Treatment for Parkinson’s Disease? 2. How Ketamine Works in teh Brain 3. New Hope for Parkinson’s Patients: Could Ketamine Treat Movement Disorder? 4. Understanding Levodopa-Induced Dyskinesia in Parkinson’s disease 5. What is Levodopa-Induced Dyskinesia? 6. Unraveling … Read more

Yale study identifies molecular mechanism behind some lissencephaly disorders.

A Promising New Target for Treating Lissencephaly: A Molecular Breakthrough Lissencephaly, a rare and devastating group of genetic disorders, affects brain development, causing a lack of normal folds and leading to seizures and intellectual disability. Sadly, there are currently no effective treatments available. However, a groundbreaking new study from Yale University offers a glimmer of … Read more